Physician
Pathology
Dr. Bogdan A. Czerniak, MD
|
|
Give Review
Bogdan Czerniak is an expert in the field of Pathology. He attended Albert Einstein College of Medicine. Doctor Bogdan A. Czerniak, MD is a published doctor as well. He has 43 publications published. The latest was: Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. Bogdan Czerniak is registered with Medicare.
Publications
- Origins of Bladder Cancer.
- Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR-2 as Targets for Growth Inhibition of Prostate Cancer.
- Summary of the 8th Annual Bladder Cancer Think Tank: Collaborating to move research forward.
- Novel neoadjuvant therapy paradigms for bladder cancer: Results from the National Cancer Center Institute Forum.
- Clinical Outcomes in cT1 Micropapillary Bladder Cancer.
- Intrinsic basal and luminal subtypes of muscle-invasive bladder cancer.
- Differential expression of GATA-3 in urothelial carcinoma variants.
- Identification of distinct Basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy.
- Frequent truncating mutations of STAG2 in bladder cancer.
- Urothelial Tumors of the Urinary Bladder in Young Patients: A Clinicopathologic Study of 59 Cases.
- HINCUTs in cancer: hypoxia-induced noncoding ultraconserved transcripts.
- Refining Patient Selection for Neoadjuvant Chemotherapy Prior to Radical Cystectomy.
- Relationship between primary and metastatic testicular germ cell tumors: a clinicopathologic analysis of 100 cases.
- In-frame cDNA library combined with protein complementation assay identifies ARL11-binding partners.
- The p63 isoform ̉Np63̱ inhibits epithelial-mesenchymal transition in human bladder cancer cells: Role of miR205.
- Genomic Variation by Whole-Genome SNP Mapping Arrays Predicts Time-to-Event Outcome in Patients with Chronic Lymphocytic Leukemia: A Comparison of CLL and HapMap Genot...
- Plasmacytoid Urothelial Carcinomas - A Chemo-sensitive Cancer with Poor Prognosis, and Peritoneal Carcinomatosis.
- Detection of bladder cancer using proteomic profiling of urine sediments.
- A Randomized Controlled Trial of Celecoxib to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer.
- The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers.
- Small cell carcinoma of the kidney: a clinicopathologic study of 14 cases.
- LDOC1 mRNA is differentially expressed in chronic lymphocytic leukemia and predicts overall survival in untreated patients.
- TMPRSS2-ERG gene fusion in small cell carcinoma of the prostate.
- Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes.
- Genome architecture marked by retrotransposons modulates predisposition to DNA methylation in cancer.
- Massive desmoplastic fibroblastoma with scapular invasion.
- Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases.
- Pleomorphic and dedifferentiated leiomyosarcoma: clinicopathologic and immunohistochemical study of 41 cases.
- Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer.
- Squamous cell carcinoma of the urinary bladder: a clinicopathologic and immunohistochemical study of 16 cases.
- Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion.
- Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases.
- Cytoplasmic sequestration of p27 via AKT phosphorylation in renal cell carcinoma.
- Fluorescence in situ hybridization is a useful ancillary diagnostic tool for extraskeletal myxoid chondrosarcoma.
- Aurora-A kinase phosphorylation of Aurora-A kinase interacting protein (AIP) and stabilization of the enzyme-substrate complex.
- Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: a contemporary review of The University of Texas M D Anderson Cancer C...
- Mutations within the kinase domain and truncations of the epidermal growth factor receptor are rare events in bladder cancer: implications for therapy.
- Pulmonary artery angiosarcoma: a clinicopathologic and radiological correlation.
- Metastatic penile cancer in a young Caucasian male: impact of delayed diagnosis.
- Specific chromosome aberrations in peripheral blood lymphocytes are associated with risk of bladder cancer.
- Phosphorylation by aurora kinase A induces Mdm2-mediated destabilization and inhibition of p53.
- Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer.
Doctors Specialties
- Anatomic Pathology
- Pathology
Accepted Insurances
- Choice Plus POS II
- American Enterprise Group
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- LocalPlus
- Open Access Plus
- Commercial Insurance Company
- Coventry Health Care
- GEHA
- Humana
- Medical Mutual of Ohio
- Medicare MCR
- Simplifi
- Thrivent Financial
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Education
-
Memorial Sloan-Kettering Cancer Center -
Albert Einstein College of Medicine
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710076310 |
| Last Name Of The Provider | CZERNIAK |
| First Name Of The Provider | BOGDAN |
| View All |
Similar Doctors
|
|
Dr. Norma M. Quintanilla, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Christopher L. Hankins, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Richard J. Ford Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Xiaoping Sun, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael W. Lieberman, MD |
|
|
Dr. Ramon L. Font, MD |
|
|
Dr. Baljit K. Nanda, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. William J. Hermann Jr., MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patricia Troncoso, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Jose A. Gomez, MD |